These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9456803)
21. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy. Kami M; Hori A; Takaue Y; Mutou Y Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886 [No Abstract] [Full Text] [Related]
25. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy]. Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886 [TBL] [Abstract][Full Text] [Related]
26. [Cancer as a specific variant of the evolutionary resistance of adapted cells to damaging factors]. Monceviciūte-Eringiene E Vopr Onkol; 2000; 46(3):255-62. PubMed ID: 10976269 [No Abstract] [Full Text] [Related]
29. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. Bacchu S; Fegan C; Neal J Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883 [No Abstract] [Full Text] [Related]
30. Complexities of targeting innate immunity to treat infection. Brown KL; Cosseau C; Gardy JL; Hancock RE Trends Immunol; 2007 Jun; 28(6):260-6. PubMed ID: 17468048 [TBL] [Abstract][Full Text] [Related]
31. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Riegger T; Conrad S; Schluesener HJ; Kaps HP; Badke A; Baron C; Gerstein J; Dietz K; Abdizahdeh M; Schwab JM Neuroscience; 2009 Feb; 158(3):1194-9. PubMed ID: 18790013 [TBL] [Abstract][Full Text] [Related]
32. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
33. Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity. Tiemessen CT; Shalekoff S; Meddows-Taylor S; Martin DJ Clin Diagn Lab Immunol; 2001 Jul; 8(4):686-9. PubMed ID: 11427411 [No Abstract] [Full Text] [Related]
34. [Cytostatic therapy reduces the immune defense. Children treated for leukemia have impaired immunity against measles and rubella]. Nilsson A; Nordin M; De Milito A; Grillner L; Chiodi F; Björk O Lakartidningen; 2000 Nov; 97(45):5116-8. PubMed ID: 11116890 [TBL] [Abstract][Full Text] [Related]
35. The immune response to fungal infections. Shoham S; Levitz SM Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679 [TBL] [Abstract][Full Text] [Related]
36. Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents. Rose B; Herder C; Löffler H; Kolb H; Martin S J Leukoc Biol; 2004 Apr; 75(4):624-30. PubMed ID: 14704370 [TBL] [Abstract][Full Text] [Related]
38. [Nonspecific resistance in patients with chronic gastritis undergoing treatment by drinking a calcium-sodium chloride low-mineralized mineral water]. Bobrov LL; Ponomarenko GN; Leshchev AL; Serebrianaia NB; Zhiburt EB Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):32-4. PubMed ID: 9771143 [No Abstract] [Full Text] [Related]
39. Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Mahuad C; Bozza V; Pezzotto SM; Bay ML; Besedovsky H; del Rey A; Bottasso O Neuroimmunomodulation; 2007; 14(3-4):193-9. PubMed ID: 18073514 [TBL] [Abstract][Full Text] [Related]
40. [Handling of cytostatics and patients care in chemotherapy]. Mast C Z Gastroenterol; 2002 Apr; 40 Suppl 1():S76-S80. PubMed ID: 11930296 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]